Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular mechanisms of tumor progression in chronic myeloproliferative disorders.

Leukemia - 1 Apr 1994

Gaidano G, Guerrasio A, Serra A, Rege-Cambrin G, Saglio G

Abstract excerpt

We have investigated the involvement of tumor suppressor genes (p53 and RB1) and dominantly acting oncogenes (Ras family genes) in BCR/ABL positive and negative chronic myeloproliferative disorders (CMPD) at different stages of the disease, including 26 cases of BCR/ABL+ chronic myeloid leukemia (CML) blast crisis, 9 myelosclerosis with myeloid metaplasia, 4 polycythemia vera, 10 essential thrombocythemia, 1...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chronic Disease
Share to Fusion Proteins, bcr-abl
Share to BCR gene

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genes, p53

Share to Genes, ras

Share to Genes, Retinoblastoma

Share to Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Share to Mutation

Source

Identifiers

PMID: 8152300

Genes

BCR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular mechanisms of tumor progression in chronic myeloproliferative disorders.PMID 8152300Read ↗

Mutations in the P53 and RAS family genes are associated with tumor progression of BCR/ABL negative chronic myeloproliferative disorders.Semantic proximity Read ↗

Molecular mechanisms in the evolution of chronic myelocytic leukemia.Semantic proximity Read ↗

The spectrum of molecular alterations in the evolution of chronic myelocytic leukemia.Semantic proximity Read ↗

Molecular events in chronic myeloid leukemia progression.Semantic proximity Read ↗

Correlation between molecular and clinical events in the evolution of chronic myelocytic leukemia to blast crisis.Semantic proximity Read ↗

RAS mutations contribute to evolution of chronic myelomonocytic leukemia to the proliferative variant.Semantic proximity Read ↗

Genetic analysis of chromosome 13 deletions in BCR/ABL negative chronic myeloproliferative disorders.Semantic proximity Read ↗

p53 tumour suppressor gene and RAS oncogenes: molecular analysis in the chronic and leukaemic phases of essential thrombocythaemia.Semantic proximity Read ↗

Role of p53 in leukemogenesis of chronic myeloid leukemia.Semantic proximity Read ↗

Expression of BCR/ABL and BCL-2 in myeloid progenitors leads to myeloid leukemias.Semantic proximity Read ↗

Correlation of RAS-Pathway Mutations and Spontaneous Myeloid Colony Growth with Progression and Transformation in Chronic Myelomonocytic Leukemia-A Retrospective Analysis in 337 Patients.Semantic proximity Read ↗

High frequency of RAS oncogene mutation in chronic myeloid leukemia patients with myeloblastoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.